This project seeks insights into the impact of microgravity on producing stem cells and stem cell-derived products in space. Using space to evaluate the steps used in terrestrial manufacturing to reprogram skin cells (fibroblasts) into stem cells capable of producing a variety of tissue types (heart, brain, and blood), could support regenerative medicine uses on Earth. Axiom Space is contributing to the NASA-funded In-Space Production Applications project through the Ax-2 mission.